Cargando…

Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China

BACKGROUND: The assessment of adherence to antiretroviral therapy (ART) is important in order to predict treatment outcomes. Lamivudine (3TC) is one of the most widely used NRTIs in China, but its concentrations in hair and association with virologic failure and drug resistance have not been studied...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Jing, Liu, Jia, Su, Bin, Pan, Xiaohong, Wang, Zhe, Wu, Jianjun, Zhang, Jiafeng, Ruan, Yuhua, Hsi, Jenny, Liao, Lingjie, Shao, Yiming, Xing, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847920/ https://www.ncbi.nlm.nih.gov/pubmed/27119346 http://dx.doi.org/10.1371/journal.pone.0154421

Ejemplares similares

HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China
por: Leng, Xuebing, et al.
Publicado: (2014)

Low Virologic Failure and Drug Resistance among HIV-Infected Patients Receiving Hospital-Based ART While Care and Outreach through Community in Guangxi, China
por: Liang, Shujia, et al.
Publicado: (2015)

Polymorphisms and Mutational Covariation Associated with Death in a Prospective Cohort of HIV/AIDS Patients Receiving Long-Term ART in China
por: Liu, Pengtao, et al.
Publicado: (2017)

Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015
por: Liu, Pengtao, et al.
Publicado: (2018)

Efficacy and HIV drug resistance profile of second-line ART among patients having received long-term first-line regimens in rural China
por: Wang, Jing, et al.
Publicado: (2015)

Virologic response and breakthrough in chronic hepatitis B Egyptian patients receiving lamivudine therapy
por: Ismail, Sohair, et al.
Publicado: (2014)

Incidence and Associated Factors of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving Antiretroviral Treatment
por: Xing, Hui, et al.
Publicado: (2013)

Relationship Between Drug Resistance and Death in HIV-Infected Patients Receiving Antiretroviral Therapy — 7 PLADs, China, 2010−2019
por: Zhang, Tianhao, et al.
Publicado: (2021)

Impact of HIV Pretreatment Drug Resistance on Virological Failure After One-Year Antiretroviral Therapy — China, 2018–2019
por: Li, Miaomiao, et al.
Publicado: (2022)

Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011–2012
por: Wang, Jing, et al.
Publicado: (2014)

Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China
por: Liao, Lingjie, et al.
Publicado: (2013)

Molecular transmission network of pretreatment drug resistance among human immunodeficiency virus-positive individuals and the impact of virological failure on those who received antiretroviral therapy in China
por: Chen, Hongli, et al.
Publicado: (2022)

Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China
por: Zuo, Zhongbao, et al.
Publicado: (2016)

Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression
por: Carbone, Alessia, et al.
Publicado: (2014)

Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
por: Maggiolo, Franco, et al.
Publicado: (2017)

Treatment outcomes and HIV drug resistance of patients switching to second-line regimens after long-term first-line antiretroviral therapy: An observational cohort study
por: Cao, Pi, et al.
Publicado: (2018)

Clinical, Immunological and Virological Responses of Zidovudine-Lamivudine-Nevirapine versus Zidovudine-Lamivudine-Efavirenz Antiretroviral Treatment (ART) Among HIV-1 Infected Children: Asella Teaching and Referral Hospital, South-East Ethiopia
por: Sorsa, Abebe
Publicado: (2018)

Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China
por: Su, Mingze, et al.
Publicado: (2018)

Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients
por: Jung, Young Kul, et al.
Publicado: (2011)

Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1
Publicado: (2019)

Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
por: Maggiolo, Franco, et al.
Publicado: (2022)

Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks
por: Rolle, Charlotte-Paige, et al.
Publicado: (2023)

The development of drug resistance mutations K103N Y181C and G190A in long term Nevirapine-containing antiviral therapy
por: Wang, Yuncong, et al.
Publicado: (2014)

Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China
por: Liu, Pengtao, et al.
Publicado: (2022)

Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study
por: Kan, Wei, et al.
Publicado: (2017)

Association of Hair Concentrations of Antiretrovirals with Virologic Outcomes Among People Living with HIV in Guangxi, China
por: Zhang, Quan, et al.
Publicado: (2021)

Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China
por: Wu, Yan, et al.
Publicado: (2022)

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort
por: Rokx, Casper, et al.
Publicado: (2014)

Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features
por: Poortahmasebi, Vahdat, et al.
Publicado: (2015)

1023. Suppressed Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide vs. Dolutegravir/Lamivudine: Virologic Failure and Durability
por: Pierone, Gerald, et al.
Publicado: (2023)

HIV drug resistance in patients in China’s national HIV treatment programme who have been on first-line ART for at least 9 months
por: Liu, Pengtao, et al.
Publicado: (2020)

Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice
por: Borghetti, Alberto, et al.
Publicado: (2019)

Association of Self-Reported Adherence and Antiretroviral Drug Concentrations in Hair Among Youth with Virologic Failure in Tanzania
por: Tabb, Zachary, et al.
Publicado: (2017)

Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort study
por: Tang, Zhenzhu, et al.
Publicado: (2017)

Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
por: Kim, Hong Joo, et al.
Publicado: (2016)

Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China
por: Liu, Lei, et al.
Publicado: (2019)

The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China
por: Gan, Mengze, et al.
Publicado: (2021)

Spatiotemporal Patterns of CRF07_BC in China: A Population-Based Study of the HIV Strain With the Highest Infection Rates
por: Gan, Mengze, et al.
Publicado: (2022)

Real-world efficacy and safety of dolutegravir plus lamivudine versus tenofovir plus lamivudine and efavirenz in ART-naïve HIV-1-infected adults
por: Li, Jin, et al.
Publicado: (2022)

Efficacy of Lamivudine or Entecavir against Virological Rebound after Achieving HBV DNA Negativity in Chronic Hepatitis B Patients
por: Miyauchi, Tomoo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n3grccbj2irn46slp17tb0g0qr